MedTrace Logo

Pacritinib Effectiveness in Real-world Settings

NCT07774455 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-08-19

No results posted yet for this study

Summary

This study aims to evaluate real-world treatment patterns and effectiveness of pacritinib, including hematologic and clinical outcomes, and survival through a site-based retrospective chart review of medical records of patients with MF.

Conditions

  • Myelofibrosis (MF)

Interventions

OTHER

Not applicable- observational study

Not Applicable - Observational Study

Sponsors & Collaborators

  • IQVIA RDS Inc.

    collaborator INDUSTRY

  • Swedish Orphan Biovitrum

    lead INDUSTRY

Principal Investigators

  • Raman Garcha, MD · Swedish Orphan Biovitrum

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2027-01-27
Completion
2027-01-27

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07774455 on ClinicalTrials.gov